rs74632023
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032119.4(ADGRV1):c.13037C>T(p.Pro4346Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00127 in 1,612,880 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P4346P) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.0066 ( 15 hom., cov: 32)
Exomes 𝑓: 0.00072 ( 14 hom. )
Consequence
ADGRV1
NM_032119.4 missense
NM_032119.4 missense
Scores
1
4
7
Clinical Significance
Conservation
PhyloP100: 5.42
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.0114275515).
BP6
?
Variant 5-90779052-C-T is Benign according to our data. Variant chr5-90779052-C-T is described in ClinVar as [Benign]. Clinvar id is 46265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-90779052-C-T is described in Lovd as [Likely_benign]. Variant chr5-90779052-C-T is described in Lovd as [Benign].
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00659 (1003/152086) while in subpopulation AFR AF= 0.0234 (969/41480). AF 95% confidence interval is 0.0221. There are 15 homozygotes in gnomad4. There are 474 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High Homozygotes in GnomAd at 14 AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRV1 | NM_032119.4 | c.13037C>T | p.Pro4346Leu | missense_variant | 64/90 | ENST00000405460.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.13037C>T | p.Pro4346Leu | missense_variant | 64/90 | 1 | NM_032119.4 | P1 | |
ADGRV1 | ENST00000425867.3 | c.1991C>T | p.Pro664Leu | missense_variant | 12/38 | 5 | |||
ADGRV1 | ENST00000640464.1 | n.3456C>T | non_coding_transcript_exon_variant | 21/21 | 5 | ||||
ADGRV1 | ENST00000639431.1 | c.265+102843C>T | intron_variant, NMD_transcript_variant | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.00657 AC: 998AN: 151968Hom.: 14 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
998
AN:
151968
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00191 AC: 474AN: 248416Hom.: 6 AF XY: 0.00150 AC XY: 202AN XY: 134720
GnomAD3 exomes
AF:
AC:
474
AN:
248416
Hom.:
AF XY:
AC XY:
202
AN XY:
134720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000719 AC: 1050AN: 1460794Hom.: 14 Cov.: 31 AF XY: 0.000647 AC XY: 470AN XY: 726702
GnomAD4 exome
AF:
AC:
1050
AN:
1460794
Hom.:
Cov.:
31
AF XY:
AC XY:
470
AN XY:
726702
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00659 AC: 1003AN: 152086Hom.: 15 Cov.: 32 AF XY: 0.00638 AC XY: 474AN XY: 74352
GnomAD4 genome
?
AF:
AC:
1003
AN:
152086
Hom.:
Cov.:
32
AF XY:
AC XY:
474
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
82
ESP6500EA
AF:
AC:
1
ExAC
?
AF:
AC:
289
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 07, 2012 | Pro4346Leu in Exon 64 of GPR98: This variant is not expected to have clinical si gnificance because it has been identified in 2.5% (76/3026) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs74632023). - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 14, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Febrile seizures, familial, 4;C2931213:Usher syndrome type 2C Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 03, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D
PrimateAI
Uncertain
T
Polyphen
D;D;.
Vest4
0.75
MVP
0.71
MPC
0.32
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at